Walmart to launch own brand of insulin amid drug price rise

Walmart has announced it will launch its own brand of insulin, aiming to cut costs for diabetics reliant on the expensive drug.

The price of insulin has skyrocketed in recent years, making it unaffordable for many suffering from diabetes. Walmart claimed that the price of its brand of insulin would be between 58 per cent and 75 per cent lower compared to other brands on the market.

The company said its insulin would cost $72.88 per vial and $85.88 per FlexPen. Walmart claimed that these prices would save users $101 per branded vial and $251 per case of branded FlexPens.